# Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

> **NCT01365494** · PHASE4 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 250 (actual)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** Purified Chick Embryo Cell Inactivated Rabies Vaccine

## Key facts

- **NCT ID:** NCT01365494
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2014-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365494, "Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01365494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*